Prognostic systems and the natural history of cirrhosis

Abstract

HCC patients treated with octreotide versus controls…..…………. 3.3.3.HCC patients treated with long-acting stomatostatin versus historical controls………..………………………………………… 3.4. Patients with ascites……………………………………………… 3.5. Epidemiological survey ………..………………………………… 4. RESULTS………………………………………………………… 70 4.1. Survival analysis………………………………………………….. 70 4.1.1. Natural history of cirrhosis…………………….………………….. 70 A. Prognosis for compensated cirrhotics…………………………... 70 B. Prognosis for decompensated cirrhotics………………………... 84 C. HCC incidence rates…………………………………………… 88 4.1.2. Treatment of type C cirrhosis……………………….…………….. 91 4.1.3. UDCA treatment for PBC patients………………………………… 94 4.1.4. Natural history of HCC……………………………………………. 100 4.1.5.